<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Conduction recovery and avoidance of permanent pacing after transcatheter aortic valve implantation</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-08-14">14 August 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Corinne</forename><surname>Marzahn</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Heart Center Brandenburg in Bernau</orgName>
								<orgName type="department" key="dep2">Medical School Brandenburg</orgName>
								<address>
									<settlement>Bernau</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Cornel</forename><surname>Koban</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Heart Center Brandenburg in Bernau</orgName>
								<orgName type="department" key="dep2">Medical School Brandenburg</orgName>
								<address>
									<settlement>Bernau</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD) a ,</roleName><forename type="first">Martin</forename><surname>Seifert</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Heart Center Brandenburg in Bernau</orgName>
								<orgName type="department" key="dep2">Medical School Brandenburg</orgName>
								<address>
									<settlement>Bernau</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Akihiro</forename><surname>Isotani</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Heart Center Brandenburg in Bernau</orgName>
								<orgName type="department" key="dep2">Medical School Brandenburg</orgName>
								<address>
									<settlement>Bernau</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Kokura Memorial Hospital</orgName>
								<address>
									<settlement>Kitakyushu</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Michael</forename><surname>Neuß</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Heart Center Brandenburg in Bernau</orgName>
								<orgName type="department" key="dep2">Medical School Brandenburg</orgName>
								<address>
									<settlement>Bernau</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD) a , Christian Butter (MD</roleName><forename type="first">Frank</forename><surname>Hölschermann</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Heart Center Brandenburg in Bernau</orgName>
								<orgName type="department" key="dep2">Medical School Brandenburg</orgName>
								<address>
									<settlement>Bernau</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<address>
									<settlement>Minneapolis</settlement>
									<region>MN</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Conduction recovery and avoidance of permanent pacing after transcatheter aortic valve implantation</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-08-14">14 August 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">3FC9E3AF07217B573C3ABDC40ADFE4A4</idno>
					<idno type="DOI">10.1016/j.jjcc.2017.06.007</idno>
					<note type="submission">Received 8 March 2017 Received in revised form 5 June 2017 Accepted 25 June 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:23+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>Transcatheter aortic valve implantation Pacemaker implantation Complete atrioventricular block Aortic stenosis Survival</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: Transcatheter aortic valve implantation (TAVI) is an established treatment option for patients with severe aortic stenosis and high surgical risk.</s><s>Currently, various prosthesis types are available.</s><s>Atrioventricular block (AVB) requiring pacemaker (PM) implantation is a typical complication after TAVI.</s><s>This study investigated the recovery of AV node conduction and mid-term outcome of patients with or without PM implantation after TAVI according to prosthesis type.</s><s>Methods: From July 2008 to May 2015, 856 transcatheter heart valves were implanted at our center (age: 80.5 AE 6.1 years; logistic EuroSCORE: 15.4%).</s><s>These patients were followed up regularly in our outpatient clinic.</s><s>Results: PM implantation was performed in 16.9% of patients due to severe conduction disturbances, mainly third-degree AVB.</s><s>The need for PM implantation differed between the various prosthesis types:</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Transcatheter aortic valve implantation (TAVI) is an established treatment option in patients with severe aortic stenosis and high surgical risk <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref>.</s><s>Although TAVI is a safe procedure, third-degree atrioventricular block (AVB) requiring pacemaker (PM) implantation remains a typical complication.</s><s>Recent studies reported a rate of PM implantation after TAVI of about 15% <ref type="bibr" target="#b4">[5]</ref>.</s><s>As the range of prosthesis types increases, the amount of data available regarding their impact on the need for PM implantation and all-cause mortality after TAVI becomes more limited.</s></p><p><s>Just how often AV node conduction is restored in patients with PM implantation after TAVI is unclear.</s><s>Recent studies reported that a relevant proportion of patients with 30-day PM after TAVI did not show PM activity at follow-up <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b5">6]</ref>.</s><s>Besides, it is uncertain how often PM reprogramming in patients after TAVI is possible to avoid right ventricular (RV) stimulation.</s></p><p><s>This study evaluated the survival outcomes of patients with or without PM implantation after TAVI according to various types of prostheses and investigated the recovery of AV nodal conduction after TAVI.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study population</head><p><s>This retrospective single-center study enrolled 856 patients with high-grade aortic stenosis who underwent TAVI at our institution from July 2008 to May 2015.</s><s>All patients were evaluated for TAVI by an interdisciplinary heart team consisting of interventional cardiologists and cardiac surgeons.</s><s>Patients received a transcatheter heart valve (THV) when the surgical risk was too high (logistic EuroSCORE &gt;20% or other severe comorbidities such as porcelain aorta, previous thoracic radiation therapy, previous cardiac surgery with complications) or contraindications for cardiac surgery were present.</s><s>In all cases, TAVIs were performed transfemorally.</s><s>Initially, the Medtronic CoreValve prosthesis was used exclusively.</s><s>The Edwards Sapien XT prosthesis has been implanted at our heart center since 2009.</s><s>In 2013, the range of products offered was expanded to include the Direct Flow Medical and the St. Jude Medical Portico prostheses and, in 2014, the Boston Scientific Lotus and the Edwards Sapien 3 prostheses were added.</s><s>In addition, Medtronic Evolut R prostheses have been available at our institution since 2015.</s><s>Prostheses were selected by the implanting cardiologist before intervention based on the patients' morphologies.</s></p><p><s>The baseline characteristics of patients during their stay in hospital were collected retrospectively from the patients' medical records.</s><s>The present study complies with the ethical guidelines of our institution.</s><s>Patients with PM implantation prior to TAVI were added to the cohort of patients 'without PM implantation after TAVI'.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Procedure</head><p><s>TAVI procedures were performed as previously described <ref type="bibr" target="#b0">[1]</ref>.</s><s>All procedures were done under general anesthesia in our hybrid operating room (hybrid OR).</s><s>The main indication for PM implantation after TAVI was third-degree AVB.</s><s>Other indications were second-degree AVB, first-degree AVB plus left bundle branch block (LBBB), and bradycardia.</s><s>Patients received their PM either periprocedurally immediately after TAVI in our hybrid OR or later during their stay in hospital.</s><s>A small number of patients underwent PM implantation after discharge.</s><s>Some patients were implanted at other institutions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Follow-up</head><p><s>Patients were examined during regular follow-up visits to our outpatient clinic.</s><s>Patients who were unable to attend the follow-up visits were followed up by phone.</s><s>Follow-up consisted of clinical examinations, New York Heart Association status, transthoracic echocardiography with control of prosthesis function and laboratory tests including N-terminal pro-brain natriuretic peptide (NT-proBNP) as a marker of neurohumoral activation.</s><s>Additionally, patients with PM implantation after TAVI received a PM check including pacing mode, heart rate (HR), and ventricular pacing (VP) percentage.</s><s>In cases of RV stimulation, VVI mode 30 min À1 was programmed with respect to an intrinsic AV conduction as a sign of recovery of AV nodal function.</s><s>If appropriate, the PM was reprogrammed in patients with intrinsic AV conduction at HR !50 min À1 (checked in VVI mode 30 min À1 ) in order to avoid RV stimulation.</s><s>In addition, the amount of RV pacing was evaluated.</s><s>We used a cut-off value of 50% RV pacing describing sufficient AV conduction, because this value was previously found to be beneficial for PM patients <ref type="bibr" target="#b7">[7]</ref>.</s><s>Missing values were supplemented by information provided by the patients' general practitioners and cardiologists.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Continuous variables were presented in normal distribution as means AE standard deviation when distributed normally, otherwise they were presented as median plus interquartile range (IQR).</s><s>Categorical variables were expressed as absolute numbers and percentages.</s><s>The analysis was calculated by t-test, x 2 -test, or Mann-Whitney U-test as appropriate.</s></p><p><s>A Kaplan-Meier survival analysis was performed.</s><s>Endpoint was the all-cause mortality.</s><s>Factors were proven as event predictors for all-cause death using univariate and multivariate analysis (Cox proportional hazard).</s><s>The multivariate analysis was performed using the parameters that showed significance in a univariate analysis using the Akaike Information Criterion and likelihood ratio test (p &lt; 0.05 significant).</s><s>Interactions between the included covariables were checked.</s><s>The open-source software 'R' version 2.15.1 (R Foundation for Statistical Computing, Vienna, Austria) was applied for all statistical tests.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Demographics</head><p><s>The cohort was a typical population with a high-risk for TAVI, advanced age (80.5 AE 6.1 years), and concomitant multimorbidity.</s><s>The median of the logistic EuroSCORE was 15.4%.</s><s>Of the 856 TAVI patients, 145 (16.9%) required a PM after TAVI due to cardiac disturbances.</s><s>Of these, 76.6% received their PM because of thirddegree AVB.</s><s>Other indications for PM implantation were seconddegree AVB (5.5%), first-degree AVB with new-onset LBBB (6.9%), cardiac syncope with new-onset LBBB (0.7%), bradyarrhythmia absoluta (5.5%), sinoatrial node disease (4.1%), and new-onset atrial fibrillation with cardiac syncope (0.7%).</s><s>Overall, in 128 patients, PM implantation was performed during hospitalization for TAVI (53 patients were implanted periprocedurally, 75 patients were implanted postprocedurally with a median of 3 days; IQR 1.0-5.0</s><s>days); 17 patients received their PM after discharge (median 421 days; IQR 183.0-523.0</s><s>days).</s></p><p><s>Of all PM patients, 89.0% received their PM within 30 days after TAVI.</s><s>Only a small group of 11.0% was implanted &gt;30 days after TAVI.</s></p><p><s>Patients with PM implantation after TAVI were significantly older (81.5 vs. 80.3 years, p = 0.012) and had a higher logistic EuroSCORE (17.5% vs. 15.0%,</s><s>p = 0.007) than patients who did not receive PM after TAVI.</s><s>For all other parameters, there were no significant differences between these two groups (Table <ref type="table" target="#tab_0">1</ref>).</s></p><p><s>Some patients already had a PM, which had been implanted previously for reasons not related to TAVI (Medtronic CoreValve prosthesis 15.8%, Edwards Sapien XT prosthesis 8.8%, Edwards Sapien 3 prosthesis 14.1%, Direct Flow Medical prosthesis 17.1%).</s></p><p><s>Core laboratory analysis of a baseline electrocardiogram (ECG) prior to TAVI was available in 142 (98.0%) patients with PM implantation after TAVI.</s><s>Patients who required PM after TAVI showed baseline ECG findings of first-degree AVB (21.8%),</s><s>LBBB (7.8%), right bundle branch block (26.8%),</s><s>QRS &gt;150 ms (19.7%), or left anterior hemiblock (12.0%).</s><s>272 patients), followed by the Boston Scientific Lotus prosthesis (21.4% of 14 patients), the Edwards Sapien 3 prosthesis (16.2% of 234), the St. Jude Medical Portico prosthesis (15.4% of 26), and the Edwards Sapien XT prosthesis (13.0% of 262 patients).</s><s>The Direct Flow Medical prosthesis shows the lowest percentage of PM implantation (7.3% of 41 patients).</s><s>Because the implant numbers for St. Jude Medical Portico, Boston Scientific Lotus and Medtronic Evolut R prostheses are low and their statistical value may be affected by uncertainty, these three prosthesis types are subsumed under the category 'other self-expandable prostheses'.</s><s>Together they show a mid-level PM percentage of 17.0% of 47 patients.</s><s>Fig. <ref type="figure" target="#fig_2">1B</ref> illustrates PM implantation rates after TAVI for the main types of prostheses used (Medtronic CoreValve, Edwards Sapien XT, Edwards Sapien 3) over the years in our institution.</s><s>The figure shows a declining rate of PM implantation which is comparable to a learning curve.</s><s>This suggests that there is a learning effect with an established intervention team.</s><s>The Medtronic CoreValve prosthesis with a PM implantation frequency of initially 32.8% dropped to 16.7% within 5 years of implantation experience at our center.</s><s>For the Edwards Sapien XT prosthesis, the PM implantation rate of 17.6% observed initially has fallen more recently to 5.9%.</s><s>Although the Edwards Sapien 3 prosthesis was introduced only recently, the rate of PM implantation associated with it decreased after only one year of usage from 20.5% to 9.1%.</s><s>Notwithstanding the strong decrease in the rate of PM implantation for the Medtronic CoreValve prosthesis over a five-year period, it was still higher than the latest PM implantation rates for the Edwards Sapien XT or Sapien 3 prostheses.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Rates of PM implantation after TAVI</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mid-term outcome</head><p><s>In the survival analysis, 96 of 711 patients without PM implantation after TAVI and 36 of 145 patients with PM implantation after TAVI had already died.</s><s>Mean follow-up time was 365 days.</s><s>After the first two years of follow-up at our institution, some patients prefer to be followed by local cardiologists to avoid the exhausting commute to the hospital.</s></p><p><s>Fig. <ref type="figure">2A</ref> depicts the Kaplan-Meier analysis after TAVI at two-year follow-up stratified by prosthesis type.</s><s>Endpoint was all-cause mortality.</s><s>The analysis showed no significantly different outcome between the various prosthesis types.</s><s>Moreover, for all-cause mortality, there was no significant difference between the subgroups of patients with or without PM implantation after TAVI for Medtronic CoreValve, Edwards Sapien XT, and Edwards Sapien 3 (without acute complications) prostheses (Fig. <ref type="figure">2B-D</ref>).</s><s>One-year mortality for patients with a Medtronic CoreValve prosthesis was up to 17%, and 23% after two years.</s><s>Of the patients with a Medtronic CoreValve prosthesis, 61.4% did not receive a PM at all, 15.8% Fig. <ref type="figure">2</ref>. Kaplan-Meier curves for all-cause mortality for various types of prostheses of the entire cohort (A), for patients without pacemaker (PM)/PM post transcatheter aortic valve implantation (TAVI)/PM pre TAVI with a Medtronic CoreValve prosthesis (B), with an Edwards Sapien XT prosthesis (C), with an Edwards Sapien 3 prosthesis (D).</s><s>In analysis of survival of PM patients with Edwards Sapien 3 prosthesis three patients were excluded, who received a TAVI and simultaneously a PM in a hemodynamical bail-out situation (cardiogenic shock) and died during hospital stay.</s><s>After exclusion there were no significant differences between patients with and without PM after Edwards Sapien 3 prosthesis implantation (Kaplan-Meier curves with and without acute complications).</s></p><p><s>already had a PM pre TAVI, and 22.8% received their PM post TAVI.</s><s>Nevertheless, these cohorts do not differ from each other in the Kaplan-Meier analysis.</s><s>One-year mortality for patients with an Edwards Sapien XT prosthesis was up to 13%, and 22% after two years.</s><s>Of those patients, 78.2% did not receive PM at all, 8.8% already had a PM pre TAVI and 13.0% received their PM post TAVI, which did not have any effect on all-cause mortality.</s><s>The one-year mortality rate for patients with Edwards Sapien 3 prosthesis was up to 21%.</s><s>Two-year follow-up data were not available at the time of the study, because we only started implanting this type of prosthesis recently.</s><s>Of these patients, 69.7% did not receive PM at all, 14.1% already had a PM pre TAVI, and in 16.2% PM was implanted post TAVI.</s><s>After excluding three patients who received a THV and, simultaneously, a PM in a hemodynamic bail-out situation (cardiogenic shock) and subsequently died in hospital, there were no significant differences between patients with and without PM after Edwards Sapien 3 prosthesis implantation.</s></p><p><s>In univariate analysis (Cox model of proportional hazards) significant outcome predictors were diabetes mellitus, LVEF &lt;35%, logistic EuroSCORE &gt;20%, eGFR &lt;30 ml/min, NT-proBNP &gt;2.000 pg/ml and aortic valve regurgitation (AR) grade !2 post TAVI (Table <ref type="table" target="#tab_1">2</ref>).</s><s>Between these parameters a multivariate analysis was performed and left ventricular ejection fraction (LVEF) &lt;35%, estimated glomerular filtration rate (eGFR) &gt;30 ml/min and AR grade !2 post TAVI presented as significant predictors for worse outcome.</s><s>PM implantation after TAVI did not show significance in the univariate analysis and was not included in the multivariate analysis.</s><s>This confirms the observation that PM implantation after TAVI may not influence survival after TAVI.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AV node conduction</head><p><s>The 145 patients with PM implantation after TAVI were scheduled for a follow-up examination (Fig. <ref type="figure" target="#fig_3">3</ref>); 36 patients had already died at the point of follow-up.</s><s>Twelve patients declined to participate, representing loss-to-follow-up.</s><s>Altogether, 97 patients were examined.</s><s>Fig. <ref type="figure" target="#fig_4">4</ref> shows the clinical follow-up course of these 97 patients.</s><s>In total, 25 patients (25%) already exhibited intrinsic AV conduction with VP 50% when entering follow-up.</s><s>Furthermore, 19 patients (20%) were discharged with intrinsic AV conduction according to PM reprogramming.</s><s>In 35% of PM patients, AV node conduction had recovered.</s><s>In these patients, PM reprogramming was either not possible (10%) because of bradycardia or AV blockages or was not recommended (25%) due to clinically insufficient rhythm (HR &lt;50 min À1 in mode VVI 30 min À1 ); 20% of PM patients (n = 19) continued to be paced and had no intrinsic AV conduction &gt;30 min À1 in mode VVI 30 min À1 at all.</s><s>Altogether, 44 (45%) patients were released with intrinsic AV conduction and 53 (55%) patients were still stimulated when leaving our follow-up.</s></p><p><s>All 19 PM-dependent patients received their PM after TAVI due to third-degree AVB.</s><s>The majority of these patients (n = 12, 63%)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The need for PM implantation remains a typical complication after TAVI, even with new generation prostheses.</s><s>The PM implantation rate of 16.9% of the entire cohort at our institution is in line with the results of other studies <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b8">8]</ref>.</s><s>The patients in the present study represent a typical TAVI cohort with high risk, advanced age, and concurrent multimorbidity.</s><s>Similar to results from the GARY register <ref type="bibr" target="#b1">[2]</ref>, our cohort was &gt;75 years old on average.</s><s>Moreover, the logistic EuroSCORE of 15.4% was comparable with 18.3% in the survey of the GARY register from 2015 <ref type="bibr" target="#b8">[8]</ref>.</s><s>Compared to the PARTNER Trial, where patients were 83.1 AE 8.6 years old and had a logistic EuroSCORE of 26.4% <ref type="bibr" target="#b0">[1]</ref>, our patients were slightly younger at 80.5 AE 6.1 years and had a lower logistic EuroSCORE of 15.4%.</s><s>Altogether, compared to those in the current literature, our study reports on a typical population at high risk for TAVI.</s><s>As patients with PM implantation after TAVI were significantly older and had a higher logistic EuroSCORE, they may be in a poorer state of health.</s></p><p><s>Moreover, baseline ECG findings prior to TAVI in patients with PM implantation after TAVI are comparable to those in current literature <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b9">9]</ref>.</s><s>Compared to the PARTNER Trial, where 18.8% of the patients with PM implantation after TAVI showed first-degree AVB, 7.1% a LBBB, and 47.6% a right bundle branch block <ref type="bibr" target="#b5">[6]</ref>, our patients displayed a slightly higher amount of first-degree AVB prior to TAVI but fewer ECG findings of LBBB and RBBB.</s></p><p><s>At 22.8%, the Medtronic CoreValve prosthesis exhibited the highest rate of PM implantation after TAVI.</s><s>This high PM implantation rate corresponds to those in the current literature <ref type="bibr" target="#b9">[9,</ref><ref type="bibr" target="#b10">10]</ref> and is in line with findings that Medtronic CoreValve prostheses show higher PM implantation rates compared to other prostheses <ref type="bibr" target="#b11">[11,</ref><ref type="bibr" target="#b12">12]</ref>.</s><s>The St. Jude Medical Portico, Boston Scientific Lotus, and Medtronic Evolut R prostheses, subsumed under the category 'other self-expandable prostheses', contained a PM percentage at medium level of 17.0%.</s><s>The Edwards Sapien XT prosthesis showed a lower PM implantation portion after TAVI with 13.0% which is in accordance with current studies <ref type="bibr" target="#b13">[13,</ref><ref type="bibr" target="#b14">14]</ref>.</s><s>Recent results of PARTNER Trial showed a lower PM implantation portion after TAVI with 8.8% <ref type="bibr" target="#b5">[6]</ref>, which conforms to results of Tarantini et al. with a PM implantation percentage of 10.0% for Edwards Sapien XT prostheses after TAVI <ref type="bibr" target="#b14">[14]</ref>.</s><s>In contrast, Alhabil et al. described a PM implantation portion of 14.5% after TAVI <ref type="bibr" target="#b15">[15]</ref> and Seeger et al. a relatively high PM percentage after TAVI with 22.0% in patients with Edwards Sapien XT prostheses <ref type="bibr" target="#b16">[16]</ref>.</s><s>Recapitulatory, our PM implantation portion after TAVI for Edwards Sapien XT prostheses represents an average of current study results.</s><s>The Edwards Sapien 3 prosthesis exposed a PM implantation percentage with 16.2% which conforms to smaller first experiences <ref type="bibr" target="#b14">[14]</ref> as well as results of the SOURCE 3 Registry that reported that at 30 days 12.3% of the patients with high surgical risk and transfemorally implanted Edwards Sapien 3 prostheses had received PM implantation after TAVI <ref type="bibr" target="#b17">[17]</ref>.</s><s>In addition, Mauri et al. observed a PM implantation portion after TAVI for Edwards Sapien 3 prosthesis with 14.4% <ref type="bibr" target="#b18">[18]</ref>.</s></p><p><s>A higher rate of PM implantation post TAVI was observed for the Edwards Sapien 3 prosthesis than for the Edwards Sapien XT prosthesis at our institution.</s><s>Moreover, considering that balloonexpandable prostheses are generally associated with lower PM implantation rates after TAVI than self-expandable prostheses, the results for the Edwards Sapien 3 prosthesis were comparatively high <ref type="bibr" target="#b13">[13]</ref>.</s><s>But, recalling our learning curve, the PM implantation rate for the Edwards Sapien 3 prosthesis decreased from 20.5% to 9.1% in the second year of implantation, which is close to the overall PM implantation rate for the Edwards Sapien XT prosthesis.</s><s>Therefore, overall PM implantation rates may decrease further with continued usage of Edwards Sapien 3 prostheses.</s><s>Lastly, at 7.3%, the Direct Flow Medical prosthesis showed the lowest PM implantation rate after TAVI, which is slightly lower than rates reported in recent studies <ref type="bibr" target="#b19">[19,</ref><ref type="bibr" target="#b20">20]</ref>.</s><s>Nevertheless they remain in a comparable range previously published.</s><s>One possible reason for this could be prophylactic PM implantation pre TAVI in patients who exhibit preexisting right bundle branch block, which is treated as a risk factor for conduction disorders after TAVI <ref type="bibr" target="#b12">[12,</ref><ref type="bibr" target="#b13">13]</ref>.</s><s>PM implantation pre TAVI results in lower PM percentages post TAVI and may not always be mentioned explicitly in current studies.</s><s>In the present study, altogether only three patients (0.4%) who showed either bradyarrythmia absoluta, sick sinus syndrome, or brady-tachy syndrome were implanted prophylactically prior to TAVI at our institution.</s></p><p><s>In our study, the most commonly used prosthesis types were associated with a decreasing PM implantation rate over the years of experience.</s><s>Although current studies reported that PM implantation after TAVI depends on the implantation depth of the prosthesis <ref type="bibr" target="#b18">[18,</ref><ref type="bibr" target="#b21">21,</ref><ref type="bibr" target="#b22">22]</ref>, varying implantation depth in order to decrease conduction disturbances after TAVI has not been pursued at our heart center.</s><s>Furthermore, we did not change implantation strategy but evaluated the measurement of the anulus by computer tomography instead of early rotational angiography in addition to transesophageal echocardiography which is more precise to define optimal size of the prosthesis.</s><s>As our implantation team consists of unvarying operators which showed an increase in experience, e.g. in the choice of prosthesis types, this highlights the importance of having experienced implantation teams to minimize the need for PM implantation after TAVI.</s></p><p><s>Based on analyses of the current literature, PM implantation after TAVI does not influence the mid-term outcome of patients, which has not yet been stratified for individual prosthesis types <ref type="bibr" target="#b4">[5]</ref>.</s><s>The present study further evaluated overall survival for patients after TAVI separated for various types of prostheses.</s><s>These extended analyses did not show any significant differences.</s><s>Moreover, overall survival was similar for patients with and without PM implantation after TAVI.</s><s>As they do not seem to show any effect on mid-term outcome, prostheses can be chosen individually.</s></p><p><s>In 45% of PM patients in our study, intrinsic AV conduction was recovered after TAVI, which coincides with observations from recent studies <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b5">6]</ref>.</s><s>Analyzing a resting ECG in patients with new PM after TAVI, Urena et al. observed pace rhythm in 66.9% of patients at 6-12 month follow-up <ref type="bibr" target="#b4">[5]</ref>.</s><s>Nazif et al. found RV pacing in 50.5% of their patients one year after TAVI <ref type="bibr" target="#b5">[6]</ref>.</s><s>At our follow-up examination, a significant proportion (20%) exhibited unnecessary RV stimulation and were reprogrammed through PM interrogation.</s><s>Intrinsic AV conduction could not be detected by single surface ECG.</s><s>This shows that PM dependency cannot be estimated solely on the basis of a single written ECG without PM interrogation and programming optimization.</s></p><p><s>There are still no generally accepted recommendations or guidelines defining the indications for PM implantation after TAVI.</s><s>PM implantation after TAVI was performed predominantly during hospitalization with a resolution by 30 days.</s><s>If PM implantation is indicated due to third-degree AVB early during TAVI procedure in the hybrid OR, the chances of recovering AV node conduction will decrease.</s><s>As mean follow-up time of our study was 365 days and patients had developed intrinsic AV conduction in the meantime, these findings might be useful for establishing a follow-up program with regular semi-annually scheduled PM checks after TAVI in order to minimize or avoid RV stimulation in PM patients after TAVI.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Limitations</head><p><s>This study was performed retrospectively at a single center.</s><s>The increasing experience of the intervention team resulted in decreasing PM implantation frequencies over the years.</s><s>This could have had an impact on the results of PM implantation percentages for each type of prosthesis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p><s>PM implantation percentages differed between the various prosthesis types but mid-term survival after TAVI was not affected.</s><s>A significant proportion of patients recovered intrinsic AV conduction, and this should be detected during PM follow-ups.</s><s>As the PM implantation percentages and the AV node conduction analyses provide practical insights into the 'real world scenario' of a high-volume center beyond study conditions, the present study can offer important guidance to cardiologists in their daily clinical routine.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig</head><label></label><figDesc><div><p><s>Fig. 1A displays the different rates of PM implantation for the various prosthesis types.</s><s>The highest rate of PM implantation after TAVI is seen for the Medtronic CoreValve prosthesis (22.8% of</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>4 ) 17 . 5 (</head><label>4175</label><figDesc><div><p><s>IQR 10.8-26.6)</s><s>0.007 c NT-proBNP pre TAVI (pg/ml) 2277.5 (IQR 994.0-5666.5)</s><s>2561.0 (IQR 1006.5-8228.5)</s><s>0.198 c Creatinine (mmol/l) 94.0 (IQR 76.0-118.0)</s><s>98.0 (IQR 79.5-125.0)</s><s>0.270 c eGFR (ml/min) 60.0 (IQR 47.0-60.0)</s><s>57.0 (IQR 42.0-60.0)</s><s>0.378 c CKI &lt;60 ml/min, n (%) 342 (48.1%) 79 (54.5%) 0.161 a CKI &lt;30 ml/min, n (%Mean echocardiographic aortic gradient (mmHg) 42.0 (IQR 31.3-54.0)</s><s>43.0 (IQR 35.0-55.0)</s><s>0.149 c Low gradient aortic stenosis, n (%) 122 (17.1%) 23 (15.9%) 0.704 a PM, pacemaker; BMI, body mass index; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; CAD, coronary artery disease; Log, logistic; NT-proBNP, N-terminal pro-brain natriuretic peptide; TAVI, transcatheter aortic valve implantation; GFR, glomerular filtration rate; CKI, chronic kidney insufficiency; LVEF, left ventricular ejection fraction.</s><s>a x 2 -test.</s><s>b T-test.</s><s>c Mann-Whitney U-test.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 1 .</head><label>1</label><figDesc><div><p><s>Fig. 1. (A) Proportion of pacemaker (PM) implantation after transcatheter aortic valve implantation (TAVI) for various types of prostheses from July 2008 to May 2015 at our institution.</s><s>Other self-expandable prostheses indicate St. Jude Medical Portico (n = 26), Boston Scientific Lotus (n = 14), and Evolut R (n = 7).</s><s>(B) Decreasing PM implantation frequencies for various types of prostheses after TAVI over the years of experience in a stable implantation team (learning curve).</s></p></div></figDesc><graphic coords="3,152.56,346.71,300.00,362.74" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 3 .</head><label>3</label><figDesc><div><p><s>Fig.3.</s><s>Flow-chart for patient inclusion to our follow-up examination.</s><s>In 145 of 856 patients, PM implantation was indicated, mainly due to third-degree atrioventricular block.</s><s>A total of 36 of these patients had already died at the point of follow-up examination.</s><s>Moreover, 12 patients could not be included and are related to the loss-to-follow-up group.</s><s>Altogether, 97 patients were included into our follow-up.</s><s>PM, pacemaker; TAVI, transcatheter aortic valve implantation.</s></p></div></figDesc><graphic coords="5,152.56,434.40,300.00,275.04" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig. 4 .</head><label>4</label><figDesc><div><p><s>Fig.4.</s><s>Follow-up examination of 97 PM patients after TAVI. 25 (25%) patients had VP 50% when entering the follow-up.</s><s>The PM could be reprogrammed in 19 (20%) of the patients.</s><s>They were discharged with intrinsic AV conduction and unnecessary RV stimulation was avoided; 19 (20%) patients did not evolve intrinsic rhythm &gt;30 min À1 and remained PM dependent; 24 (25%) patients had only insufficient intrinsic AV conduction in PM mode VVI 30 min À1 .</s><s>Furthermore in 10 (10%) patients PM reprogramming was not possible due to bradycardia or AV blockages.</s><s>Altogether a total of 44 (45%) patients were released with intrinsic AV conduction, 53 (55%) patients were still paced.</s><s>AV, atrioventricular; HR, heart rate; PM, pacemaker; TAVI, transcatheter aortic valve implantation; RV, right ventricular; VP, ventricular pacing.</s></p></div></figDesc><graphic coords="6,77.73,54.29,432.00,310.46" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="4,77.73,313.33,432.00,379.01" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Demographic data for patients with or without PM implantation after TAVI.</s></p></div></figDesc><table><row><cell>Characteristics</cell><cell>TAVI without PM</cell><cell>TAVI with PM</cell><cell>p</cell></row><row><cell>N (%)</cell><cell>711 (83.1%)</cell><cell>145 (16.9%)</cell><cell></cell></row><row><cell>Age (years)</cell><cell>80.3 AE 6.2</cell><cell>81.5 AE 5.0</cell><cell>0.012 b</cell></row><row><cell>Male, n (%)</cell><cell>318 (44.7%)</cell><cell>61 (42.1%)</cell><cell>0.557 a</cell></row><row><cell>BMI (kg/m 2 )</cell><cell>27.9 AE 9.3</cell><cell>27.2 AE 5.6</cell><cell>0.423 b</cell></row><row><cell>Diabetes mellitus, n (%)</cell><cell>273 (38.4%)</cell><cell>53 (36.6%)</cell><cell>0.677 a</cell></row><row><cell>PCI, n (%)</cell><cell>259 (36.4%)</cell><cell>50 (34.5%)</cell><cell>0.657 a</cell></row><row><cell>CABG, n (%)</cell><cell>93 (13.1%)</cell><cell>14 (9.7%)</cell><cell>0.256 a</cell></row><row><cell>CAD, n (%)</cell><cell>310 (43.6%)</cell><cell>58 (40.0%)</cell><cell>0.425</cell></row></table><note><p><s>a Log EuroSCORE (%) 15.0 (IQR 8.9-22.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p><s>Proportional hazards as event predictors for all-cause mortality in univariate and multivariate analysis (Cox-Model).</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Univariate analysis</cell><cell cols="2">Multivariate analysis</cell></row><row><cell></cell><cell>HR (95% CI)</cell><cell>p</cell><cell>HR (95% CI)</cell><cell>p</cell></row><row><cell>PM implantation</cell><cell>1.2 (0.8-1.8)</cell><cell>0.318</cell><cell></cell><cell></cell></row><row><cell>Diabetes mellitus</cell><cell>1.4 (1.0-2.0)</cell><cell>0.049</cell><cell>1.4 (1.0-2.0)</cell><cell>0.051</cell></row><row><cell>LVEF 35%</cell><cell cols="3">2.2 (1.4-3.3) &lt;0.001 1.9 (1.3-2.9)</cell><cell>0.002</cell></row><row><cell>Log. EuroSCORE &gt;20%</cell><cell>1.6 (1.1-2.3)</cell><cell>0.007</cell><cell></cell><cell></cell></row><row><cell>CAD</cell><cell>1.0 (0.7-1.5)</cell><cell>0.780</cell><cell></cell><cell></cell></row><row><cell>eGFR &lt;30 ml/min</cell><cell cols="4">2.9 (1.8-4.7) &lt;0.001 2.7 (1.7-4.3) &lt;0.001</cell></row><row><cell>NT-proBNP &gt;2.000 pg/ml</cell><cell>1.9 (1.3-2.8)</cell><cell>0.002</cell><cell></cell><cell></cell></row><row><cell cols="2">AR grade !2 (fluoroscopy) 2.1 (1.3-3.6)</cell><cell>0.004</cell><cell cols="2">2.2 (1.3-3.7) 0.004</cell></row></table><note><p><s>PM, pacemaker; LVEF, left ventricular ejection fraction; Log, logistic; CAD, coronary artery disease; eGFR, glomerular filtration rate; NT-proBNP, Nterminal pro-brain natriuretic peptide; AR, aortic valve regurgitation.</s></p></note></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>The authors would like to thank study nurses Daniela Bettin, Olga Hecht, and Martina Ninnemann for their support during patient follow-up visits and data acquisition.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p><s>None.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of interest statement</head><p><s>The authors declare that there is no conflict of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Leon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Moses</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Svensson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Tuzcu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Webb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Fontana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Makkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Block</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Guyton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Pichard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Bavaria</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">PARTNER Trial Investigators</title>
				<imprint>
			<date type="published" when="2010">2010</date>
			<biblScope unit="volume">363</biblScope>
			<biblScope unit="page" from="1597" to="1607" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The German Aortic Valve Registry (GARY): in-hospital outcome</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Hamm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Möllmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Holzhey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Beckmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Veit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Figulla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cremer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Kuck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lange</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schuler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Walther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Beyersdorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Böhm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1588" to="1598" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Transcatheter aortic valve replacement using a selfexpanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Popma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Reardon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Yakubov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Kleiman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Heimansohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hermiller</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Harrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Coselli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Diez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kafi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Schreiber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Gleason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Conte</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="1972" to="1981" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Transcatheter versus surgical aortic-valve replacement in high-risk patients</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Leon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Mack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Moses</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Svensson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Tuzcu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Webb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Fontana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Makkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dewey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kapadia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Babaliaros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">H</forename><surname>Thourani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">364</biblScope>
			<biblScope unit="page" from="2187" to="2198" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function</title>
		<author>
			<persName><forename type="first">M</forename><surname>Urena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Webb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tamburino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Muñoz-García</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cheema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Dager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Serra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Amat-Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Barbanti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Immè</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Briales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Benitez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Al</forename><surname>Lawati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Cucalon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename></persName>
		</author>
		<author>
			<persName><forename type="first">García</forename><forename type="middle">Del</forename><surname>Blanco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="1233" to="1243" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Nazif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Dizon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Hahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Babaliaros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Douglas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>El-Chami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Herrmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Makkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pichard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Tuzcu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">Y</forename><surname>Szeto</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement. The PARTNER (Placement of AoRtic TraNscathetER Valves) Trial and Registry</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Webb</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JACC Cardiovasc Interv</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="60" to="69" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Steinberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schuger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Daubert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mcnitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Andrews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zareba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Moss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Electrophysiol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="359" to="365" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY Registry</title>
		<author>
			<persName><forename type="first">T</forename><surname>Walther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Hamm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schuler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Berkowitsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kötting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mangner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mudra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Beckmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cremer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Welz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lange</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Kuck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Mohr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Möllmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="2173" to="2180" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Safety of a conservative strategy of permanent pacemaker implantation after transcatheter aortic CoreValve implantation</title>
		<author>
			<persName><forename type="first">M</forename><surname>De Carlo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Giannini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bedogni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Klugmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Brambilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Marco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Zucchelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Testa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Oreglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Petronio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am Heart J</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="page" from="492" to="499" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Permanent pacemaker insertion after Corevalve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative)</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Z</forename><surname>Khawaja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rajani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Khavandi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Moynagh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chowdhary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Spence</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Q</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Trivedi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hutchinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Belder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Moat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Blackman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="951" to="960" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Propensity-matched comparison between Direct Flow Medical, Medtronic Corevalve, and Edwards Sapien XT prostheses: device success, thirty-day safety, and mortality</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Pyxaras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wolf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Schmitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Naber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Catheter Cardiovasc Interv</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="1217" to="1225" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Conduction disorders in the setting of transcatheter aortic valve implantation: a clinical perspective</title>
		<author>
			<persName><forename type="first">C</forename><surname>Fraccaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Napodano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tarantini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Catheter Cardiovasc Interv</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="1217" to="1223" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Complications of transcatheter aortic valve implantation (TAVI): how to avoid and treat them</title>
		<author>
			<persName><forename type="first">H</forename><surname>Möllmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kempfert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Walther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hamm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Heart</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="900" to="908" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Unravelling the (arte)fact of increased pacemaker rate with the Edwards Sapien 3 valve</title>
		<author>
			<persName><forename type="first">G</forename><surname>Tarantini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mojoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Purita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Napodano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>'onofrio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Frigo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Covolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Facchin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Isabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gerosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Iliceto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EuroIntervention</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="343" to="350" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Improvement in transcatheter aortic valve replacement outcome using the new generation SAPIEN 3 device: a single center experience</title>
		<author>
			<persName><forename type="first">B</forename><surname>Alhabil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Amabile</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Veugeois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dibie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Phillippe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Caussin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="B255" to="256" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Comparison of the second generation Edwards Sapien 3 valve with the Edwards Sapien XT for transfemoral aortic valve implantation (TAVI)</title>
		<author>
			<persName><forename type="first">J</forename><surname>Seeger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gonska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rodelwald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Marcovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Scharnbeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Rottbauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wöhrle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page">B258</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">SOURCE 3 Registry. Design and 30-day results of the European Postapproval Registry of the latest generation of the SAPIEN 3 Transcatheter Heart Valve</title>
		<author>
			<persName><forename type="first">O</forename><surname>Wendler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schymik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Treede</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Baumgartner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Dumonteil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ihlberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Neumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tarantini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Zamarano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vahanian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="1123" to="1132" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Predictors of permanent pacemaker implantation after transcatheter aortic valve replacement with the Sapien 3</title>
		<author>
			<persName><forename type="first">V</forename><surname>Mauri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Reimann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Stern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Scherner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kuhn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Rudolph</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rosenkranz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Eghbalzadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Friedrichs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wahlers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Baldus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Madershahian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Rudolph</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JACC Cardiovasc Interv</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="2200" to="2209" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve</title>
		<author>
			<persName><forename type="first">J</forename><surname>Schofer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Colombo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Klugmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fajadet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Demarco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Tchétché</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Maisano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bruschi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Latib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bijuklic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Weissman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Low</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Redwood</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="763" to="768" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve</title>
		<author>
			<persName><forename type="first">H</forename><surname>Treede</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tübler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Reichenspurner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Grube</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pascotto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Franzen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mueller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Low</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Bolling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Meinertz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schofer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Thorac Cardiovasc Surg</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="page" from="897" to="903" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Implantation depth measured by 64-slice computed tomography is associated with permanent pacemaker requirement following transcatheter aortic valve implantation with the Core Valve system</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kammler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Blessberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fellner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kypta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lambert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Engl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hönig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lichtenauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Grund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kerschner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Saleh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Steinwender</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="513" to="518" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Optimal implantation depth and adherence to guidelines on permanent pacing to improve the results of transcatheter aortic valve replacement with the Medtronic CoreValve System</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Petronio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Sinning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">V</forename><surname>Mieghem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zucchelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nickenig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bekeredjian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bosmans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bedogni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Branny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stangl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kovac</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schiltgen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kraus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>De Jaegere</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JACC Cardiovasc Interv</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="837" to="846" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
